Surgeons Explain Why CABG Won the SYNTAX Trial Surgery remains standard of care for higher-risk patients
Coronary artery bypass grafting (CABG) still holds several clear-cut advantages over percutaneous coronary intervention (PCI), according to surgeons who revisited the data from the SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) trial.